Intellipharmaceutics International Inc. (IPCI)

[fabius]

ipci is not going to regain NASDAQ compliance with just improving sales on the two generics already marketed.

those attending the meeting reported that NASDAQ compaliance is a non issue for them.

to me this means:
either they are just lying, knowing that they will made another raise which will crash the stock price and get us delisted

or

the next development they have been alluding to is remarkably more important that any possible improvement on seroquel sales.

over the past months I repeated several times two key (to me) concepts :

- generics are not going to cause any major change (that was the old scenario, 3yrs ago, not anymore)
- raising money through new shares offering is going to kill us

They have been both proved true and are becoming even more crucial now.

ipci management is going to decide the future of the company as a listed co in the coming weeks, besides our future as investors.